Green synthesis and 3D pharmacophore study of pyrimidine and glucoside derivatives with in vitro potential anticancer and antioxidant activities
Salem, MA; Behalo, MS; Elrazaz, Eman;
Abstract
A facile and an efficient one-pot green synthesis of pyrimidine derivatives using the environmentally friendly Cerium(IV) ammonium nitrate (CAN) as catalyst and water as a solvent has been described. Some of the synthesized pyrimidines react with 2,3,4,6-tetra-O-acetyl-α-d-glucopyranosyl bromide in ethanol containing potassium hydroxide to give S-glucoside derivatives. The structures of the newly synthesized compounds were elucidated on the basis of their spectral and elemental analyses. In addition, selected derivatives of the products were screened for their anticancer activities against four tumor cell lines using MTT assay and the results showed that some of these compounds have potent cytotoxic effect, as concluded from their IC50 values. Molecular modeling studies including generation of a 3D pharmacophore model were carried out. The study showed high correlation with the experimental results. Antioxidant activity of the synthesized products was also investigated and most of them showed potent activity.
Other data
Title | Green synthesis and 3D pharmacophore study of pyrimidine and glucoside derivatives with in vitro potential anticancer and antioxidant activities | Authors | Salem, MA; Behalo, MS; Elrazaz, Eman | Keywords | Pyrimidine; Cerium (IV) ammonium nitrate; S-glucoside; Pharmacophore; Anticancer; Antioxidant; IV AMMONIUM-NITRATE; MASS-SPECTROMETRIC FRAGMENTATION; BIOLOGICAL EVALUATION; SEQUENTIAL SYNTHESIS; DESIGN; SPECTRA | Issue Date | 2019 | Publisher | SPRINGER BIRKHAUSER | Journal | MEDICINAL CHEMISTRY RESEARCH | ISSN | 1054-2523 | DOI | 10.1007/s00044-019-02367-9 | Scopus ID | 2-s2.0-85066459299 | Web of science ID | WOS:000472968400010 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.